−23.54 MILS
560.00 KILS
74.53 M
About D.N.A BIOMED
Sector
Industry
CEO
Ori Altschuler
Headquarters
Tel Aviv
Employees (FY)
13
Founded
2004
ISIN
IL0011038523
FIGI
BBG000PNGQ97
DNA Group (T.R.) Ltd. engages in investing in biomedical companies and real estate. Through its portfolio companies, it provides ultrasound systems for diagnosing bone strength and density and monitoring calcium leakage, as well as oral drugs for the treatment of osteoporosis. The company was founded on October 24, 2004 and is headquartered in Tel Aviv, Israel.
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
The current price of DNA is 88.8 ILA — it has decreased by 4.93% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on TASE exchange D.N.A BIOMED stocks are traded under the ticker DNA.
DNA stock is 9.54% volatile and has beta coefficient of 0.02. Check out the list of the most volatile stocks — is D.N.A BIOMED there?
Yes, you can track D.N.A BIOMED financials in yearly and quarterly reports right on TradingView.
DNA stock has risen by 5.21% compared to the previous week, the month change is a 22.48% rise, over the last year D.N.A BIOMED has showed a 28.32% increase.
Today D.N.A BIOMED has the market capitalization of 109.37 M, it has decreased by 3.91% over the last week.
No, DNA doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, DNA shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade D.N.A BIOMED stock right from TradingView charts — choose your broker and connect to your account.
As of Apr 20, 2024, the company has 13.00 employees. See our rating of the largest employees — is D.N.A BIOMED on this list?
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So D.N.A BIOMED technincal analysis shows the buy rating today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating D.N.A BIOMED stock shows the neutral signal. See more of D.N.A BIOMED technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.